Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

316
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
316

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease.

Blood advances·2026
Same author

From Ink to Mockup: An Integrated Study of Historical Gall Ink Formulations and Their Impact on Paper.

ChemPlusChem·2026
Same author

ENT1 inhibition enhances weight control and metabolic health in diet-induced obesity.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Neuroepithelial VIP-VIPR1 interactions differentially control enteric type 1 and type 2 immunity.

Nature immunology·2025
Same author

Enteric nervous system-derived VIP restrains differentiation of LGR5<sup>+</sup> stem cells toward the secretory lineage impeding type 2 immune programs.

Nature immunology·2025
Same author

High Fat and Sugar Diet Increases Enteric cDC1 and Oral Antigen-Specific Tregs.

Journal of immunology research·2025

相关实验视频

Updated: May 12, 2025

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.5K

工程神经素U促进2型先天性免疫和急性损伤中的再生保护.

Sara Trindade-Correia1,2,3, Vasco Correia1, Filipe Delgado1

  • 1LiMM Therapeutics, Lisboa, Portugal.

Journal of the American Society of Nephrology : JASN
|May 8, 2025
PubMed
概括

一种经过工程设计的神经美丁U类型,LIMM102,显示了急性损伤 (AKI) 的治疗潜力. 在临床前模型中,这种治疗通过通过NMUR1信号来激活2型先天性淋巴细胞 (ILC2s) 来改善功能和存活率.

更多相关视频

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.3K
The Mouse Isolated Perfused Kidney Technique
08:19

The Mouse Isolated Perfused Kidney Technique

Published on: November 17, 2016

21.5K

相关实验视频

Last Updated: May 12, 2025

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.5K
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.3K
The Mouse Isolated Perfused Kidney Technique
08:19

The Mouse Isolated Perfused Kidney Technique

Published on: November 17, 2016

21.5K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 免疫学 免疫学 免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 急性损伤 (AKI) 是一种严重的疾病,其特点是功能突然丧失.
  • 2型先天性淋巴细胞 (ILC2s),由神经美丁U (NMU) 激活,在组织修复和平衡中发挥作用.
  • 在AKI模型中,脏ILC2s已经显示出保护作用.

研究的目的:

  • 为了研究LIMM102的治疗疗效,一个工程NMU模拟,在缺血-再输液损伤 (IRI) 诱导的AKI的临床前模型中.
  • 确定LIMM102的作用背后的机制,特别是其依赖NMUR1信号和ILC2激活.

主要方法:

  • 将LIMM102给受IRI诱导的AKI影响的野生型小鼠.
  • 评估存活率,质过率 (GFR),功能生物标志物和组织病理学.
  • 评估LIMM102在NMUR1缺乏小鼠中的疗效,以确认NMUR1信号的必要性.

主要成果:

  • 在IRI诱导的AKI小鼠中,LIMM102治疗显著降低了死亡率.
  • LIMM102的使用改善了GFR,降低了损伤生物标志物,并降低了病变的严重程度.
  • LIMM102的治疗效益取决于NMUR1的信号传递,Nmur1缺乏的小鼠缺乏效果证明了这一点.

结论:

  • 在IRI诱导的AKI中,LIMM102显示出显著的保护作用.
  • LIMM102的治疗作用通过NMUR1信号传递进行介导,并与脏ILC2s的激活有关.